TY - JOUR AU - Wilhelm, S. M. AU - Wilhelm, S. M. AU - Dumas, J. AU - Adnane, L. PY - 2011 DA - 2011// TI - Regorafenib (BAY 73–4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity JO - Int J Cancer VL - 129 UR - https://doi.org/10.1002/ijc.25864 DO - 10.1002/ijc.25864 ID - Wilhelm2011 ER - TY - JOUR AU - Mross, K. AU - Frost, A. AU - Steinbild, S. PY - 2012 DA - 2012// TI - A phase I dose-escalation study of regorafenib (BAY 73–4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-1900 DO - 10.1158/1078-0432.CCR-11-1900 ID - Mross2012 ER - TY - JOUR AU - Strumberg, D. AU - Scheulen, M. E. AU - Schulteis, B. PY - 2012 DA - 2012// TI - Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study JO - Br J Cancer VL - 106 UR - https://doi.org/10.1038/bjc.2012.153 DO - 10.1038/bjc.2012.153 ID - Strumberg2012 ER - TY - JOUR AU - Grothey, A. AU - Cutsem, E. AU - Sobrero, A. F. PY - 2013 DA - 2013// TI - Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebocontrolled, phase 3 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61900-X DO - 10.1016/S0140-6736(12)61900-X ID - Grothey2013 ER - TY - JOUR AU - Demetri, G. D. AU - Reichardt, P. AU - Kang, Y. PY - 2013 DA - 2013// TI - Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61857-1 DO - 10.1016/S0140-6736(12)61857-1 ID - Demetri2013 ER - TY - JOUR AU - Wit, M. AU - Boers-Doets, C. B. AU - Saettini, A. AU - Vermeersch, K. AU - Juan, C. R. AU - Ouwerkerk, J. AU - Raynard, S. S. AU - Bazin, A. AU - Cremolini, C. PY - 2014 DA - 2014// TI - Prevention and management of adverse events related to regorafenib JO - Support Care Cancer VL - 22 UR - https://doi.org/10.1007/s00520-013-2085-z DO - 10.1007/s00520-013-2085-z ID - Wit2014 ER - TY - JOUR AU - Bernal, W. AU - Auzinger, G. AU - Dhawan, A. AU - Wendon, J. PY - 2010 DA - 2010// TI - Acute liver failure JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60274-7 DO - 10.1016/S0140-6736(10)60274-7 ID - Bernal2010 ER - TY - JOUR AU - Scott, T. R. AU - Kronsten, V. T. AU - Hughes, R. D. AU - Shawcross, D. L. PY - 2013 DA - 2013// TI - Pathophysiology of cerebral oedema in acute liver failure JO - World J Gastroenterol VL - 19 UR - https://doi.org/10.3748/wjg.v19.i48.9240 DO - 10.3748/wjg.v19.i48.9240 ID - Scott2013 ER - TY - JOUR AU - Tlemsani, C. AU - Mir, O. AU - Boudou-Rouquette, P. AU - Huillard, O. AU - Maley, K. AU - Ropert, S. AU - Coriat, R. AU - Goldwasser, F. PY - 2011 DA - 2011// TI - Posterior reversible encephalopathy syndrome induced by anti-VEGF agents JO - Target Oncol VL - 6 UR - https://doi.org/10.1007/s11523-011-0201-x DO - 10.1007/s11523-011-0201-x ID - Tlemsani2011 ER - TY - JOUR AU - Myint, Z. W. AU - Sen, J. M. AU - Watts, N. L. AU - Druzgal, T. J. AU - Nathan, B. R. AU - Ward, M. D. AU - Boyer, J. E. AU - Fracasso, P. M. PY - 2014 DA - 2014// TI - Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors JO - Clin Colorectal Cancer VL - 13 UR - https://doi.org/10.1016/j.clcc.2013.12.003 DO - 10.1016/j.clcc.2013.12.003 ID - Myint2014 ER -